Member Info for ShareSting

This is not a vaccine.
This is a drug designed to support the bodies natural defence. If it works it can be used as both a proactive and reactive drug dependent on patient needs.

The trial is ending this week for the first patient. ( 2 weeks dosage + 2 weeks monitoring)

So the company might update, their could be a leak or Richard might push ahead with the Interviews.

I topped up today. Late trades should be interesting again !

Interferon Beta 1a direct to lungs will be critical whilst multiple vaccines are created.
33 different strains is a nightmare.

JBER is controlling the price.
When they are finished we will move and quickly.

You can take pills if it does !!

Just grabbed another 1849 shares.
Think today is starting to see a change.
Probably kiss of death !

I believe .... as you know

Woodstock the priority for Richard is to gain enough data to achieve MHRA and ideally FDA approval.

Additional studies (home study, combo studies) will take time but potentially add further value to the business.

Personally I think the business is seeing positive results and will want to achieve MHRA sign off as a priority.

I have just dropped Richard a quick email asking if he could bring forward a interview with Andrew Scott or one of the journalists keen to chat to him.
I have explained that following increasing global chatter on the use of Interferon Alpha and Interferon Beta, it would be hugely beneficial to hear from an expert like himself.
Just to be clear, he wouldn’t be able to comment on the trial without an RNS. I’m not expecting this for a week or two.
He could comment on the reshape of Synairgen and how trials are being coordinated.

I understand investors wanting news, but equally we want the business to deliver the results so we receive MHRA and FDA approval ASAP.

if People are so desperate for a update, contact the company and stop moaning.
We released 26m shares at 35p last week. Some here were forecasting the share to drop to 35p. It is holding 50p and everyday more news on Interferon lands.

The company are not obligated to inform the markets during the trial. This is not about the day trade. You can tell who have done their research and who want a 36hr quick return.

No news is good news.
They would have to inform the market if the trial was not working. The 12 week clinical trial has been approved by MHRA and that is what they are running. They are under no obligation to update the markets. All focus is on delivering the outcome all genuine holders want. MHRA and FDA approval.

People that suggest the Board need to be quick, or we will miss the train shouldn’t be invested here sorry.

The board have been ultra quick in the last 8 weeks as detailed. As for SNG001 it was being developed for Asthma and COPD... those trains are still in the station. The Corona train is not even reached the station with a vaccine months and months away.

People also have to realise that this isn’t about updating the market every minute. They will be updating WHO and MHRA on progress. We might get a leak from a hospital or patient, that will be it. Richard will also hopefully update us on what they are doing as a business.

Anyone wanting a day trade pump and dump should head elsewhere.

I don’t think most understand what the team at Synairgen have achieved in the last 8 weeks.

They have gone from a team of 16 to close to a team of 80.
They have raised £14m
They have created four clear work streams : clinical hospital, regulatory, manufacturing and clinical home.
The have written, submitted and had a approved the clinical study ahead of others.
They have been coordinating one of the most important studies in the UK.

Yes the share price has dropped due to the placing. But look what they have achieved and look what is happening in the world in regards to Interferon Beta !

So today we have another 1.5m of delayed buys and sells.
There is a reason for this and if a buyer continues to accumulate they don’t need to declare until they stop.... good old AiM !

So my guess and this is a guess not fact, I believe a company is buying the flipper shares and accumulating up to 30%. They have been dining on the placing shares and are happy to buy at what they see as a discount to true value (once SNG001 is approved). If the can buy 30% at an average of 70p and have to spend £5 per share for the rest, that significantly reduces their average buy price.

As I say, I have No intel on this, unlike my other posts which are backed by a source.

Miggy you are right.
Richard confirmed that there would be no RNS updates. He has agreed to offer some PR and Marketing which should land soon.

The tests we don’t want any RNS’s at this stage it is too early. We might get and RNS on potential merger talks or take over talks, but I’m not expecting them for at least 4 weeks.

Anything can happen including leaks outside of the companies control.

I personally have been pushing Richard for an update on Interferon and how SNG001 compares to other drugs being trialled.

I take it you are seeing the delayed trades showing.
Someone is selling but equally someone is buying.

Bristol and others !!!

When JBER move of the offer this will fly !
It seems they are selling the placing shares. Similar story before.

All good and happy with my sub 55p top up.

No rush guys.

As the flippers finish we will be heading back toward 70’s.
Anyone topping up at this level will be happy.
I’m not expecting and RNS update. I am expecting some company PR.

Don’t forget No New Is Good News !

The churn is a result of the placing. This share is too big to trade so I’m just sitting tight and topping up.

GLA

As I said yesterday and today.
If you are a trader this is not a share for you !